Literature DB >> 19805108

Orthogonal analytical approaches to detect potential contaminants in heparin.

Marco Guerrini1, Zhenqing Zhang, Zachary Shriver, Annamaria Naggi, Sayaka Masuko, Robert Langer, Benito Casu, Robert J Linhardt, Giangiacomo Torri, Ram Sasisekharan.   

Abstract

Heparin is a widely used anticoagulant and antithrombotic agent. Recently, a contaminant, oversulfated chondroitin sulfate (OSCS), was discovered within heparin preparations. The presence of OSCS within heparin likely led to clinical manifestations, most prevalently, hypotension and abdominal pain leading to the deaths of several dozens of patients. Given the biological effects of OSCS, one continuing item of concern is the ability for existing methods to identify other persulfonated polysaccharide compounds that would also have anticoagulant activity and would likely elicit a similar activation of the contact system. To complete a more extensive analysis of the ability for NMR and capillary electrophoresis (CE) to capture a broader array of potential contaminants within heparin, we completed a systematic study of NMR, both mono- and bidimensional, and CE to detect both various components of sidestream heparin and their persulfonated derivatives. We show that given the complexity of heparin samples, and the requirement to ensure their purity and safety, use of orthogonal analytical techniques is effective at detecting an array of potential contaminants that could be present.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19805108      PMCID: PMC2749844          DOI: 10.1073/pnas.0906861106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Structure and biological interactions of heparin and heparan sulfate.

Authors:  B Casu; U Lindahl
Journal:  Adv Carbohydr Chem Biochem       Date:  2001       Impact factor: 12.200

2.  2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity.

Authors:  Robert J Linhardt
Journal:  J Med Chem       Date:  2003-06-19       Impact factor: 7.446

Review 3.  Toward a biotechnological heparin through combined chemical and enzymatic modification of the Escherichia coli K5 polysaccharide.

Authors:  A Naggi; G Torri; B Casu; P Oreste; G Zoppetti; J P Li; U Lindahl
Journal:  Semin Thromb Hemost       Date:  2001-10       Impact factor: 4.180

Review 4.  Production and chemical processing of low molecular weight heparins.

Authors:  R J Linhardt; N S Gunay
Journal:  Semin Thromb Hemost       Date:  1999       Impact factor: 4.180

5.  Effect of substitution pattern on 1H, 13C NMR chemical shifts and 1J(CH) coupling constants in heparin derivatives.

Authors:  E A Yates; F Santini; B De Cristofano; N Payre; C Cosentino; M Guerrini; A Naggi; G Torri; M Hricovini
Journal:  Carbohydr Res       Date:  2000-10-20       Impact factor: 2.104

6.  "Fast moving" and "slow moving" heparins, dermatan sulfate, and chondroitin sulfate: qualitative and quantitative analysis by agarose-gel electrophoresis.

Authors:  N Volpi
Journal:  Carbohydr Res       Date:  1993-09-02       Impact factor: 2.104

7.  Analysis of pharmaceutical heparins and potential contaminants using (1)H-NMR and PAGE.

Authors:  Zhenqing Zhang; Boyangzi Li; Jiraporn Suwan; Fuming Zhang; Zhenyu Wang; Haiying Liu; Barbara Mulloy; Robert J Linhardt
Journal:  J Pharm Sci       Date:  2009-11       Impact factor: 3.534

8.  Sulfation of some chemically-modified heparins. Formation of a 3-sulfate analog of heparin.

Authors:  R N Rej; K G Ludwig-Baxter; A S Perlin
Journal:  Carbohydr Res       Date:  1991-03-20       Impact factor: 2.104

Review 9.  Patterns of sulphation in heparan sulphate: polymorphism based on a common structural theme.

Authors:  J T Gallagher; J E Turnbull; M Lyon
Journal:  Int J Biochem       Date:  1992-04

10.  Fractionation and structural features of two heparin families with high antithrombotic, antilipemic and anticoagulant activities.

Authors:  P Bianchini; B Osima; B Parma; H B Nader; C P Dietrich; B Casu; G Torri
Journal:  Arzneimittelforschung       Date:  1985
View more
  27 in total

1.  Structural characterization of heparins from different commercial sources.

Authors:  Fuming Zhang; Bo Yang; Mellisa Ly; Kemal Solakyildirim; Zhongping Xiao; Zhenyu Wang; Julie M Beaudet; Amanda Y Torelli; Jonathan S Dordick; Robert J Linhardt
Journal:  Anal Bioanal Chem       Date:  2011-09-20       Impact factor: 4.142

2.  Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido-alpha-D-glucopyranose (1,4) 2-O-sulfo-alpha-L-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages.

Authors:  Zhongping Xiao; Wenjing Zhao; Bo Yang; Zhenqing Zhang; Huashi Guan; Robert J Linhardt
Journal:  Glycobiology       Date:  2010-08-20       Impact factor: 4.313

3.  Linear polyalkylamines as fingerprinting agents in capillary electrophoresis of low-molecular-weight heparins and glycosaminoglycans.

Authors:  J Timothy King; Umesh R Desai
Journal:  Electrophoresis       Date:  2011-10-17       Impact factor: 3.535

4.  Oversulfated chondroitin sulfate is not the sole contaminant in heparin.

Authors:  Jing Pan; Yi Qian; Xiaodong Zhou; Andrew Pazandak; Sarah B Frazier; Peter Weiser; Hong Lu; Lijuan Zhang
Journal:  Nat Biotechnol       Date:  2010-03       Impact factor: 54.908

5.  Discovery of an intrinsic tenase complex inhibitor: Pure nonasaccharide from fucosylated glycosaminoglycan.

Authors:  Longyan Zhao; Mingyi Wu; Chuang Xiao; Lian Yang; Lutan Zhou; Na Gao; Zi Li; Jun Chen; Jianchao Chen; Jikai Liu; Hongbo Qin; Jinhua Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-22       Impact factor: 11.205

6.  Structure and activity of a new low-molecular-weight heparin produced by enzymatic ultrafiltration.

Authors:  Li Fu; Fuming Zhang; Guoyun Li; Akihiro Onishi; Ujjwal Bhaskar; Peilong Sun; Robert J Linhardt
Journal:  J Pharm Sci       Date:  2014-03-14       Impact factor: 3.534

7.  Modulation of heparan sulfate biosynthesis by sodium butyrate in recombinant CHO cells.

Authors:  Payel Datta; Bo Yang; Robert J Linhardt; Susan T Sharfstein
Journal:  Cytotechnology       Date:  2014-01-29       Impact factor: 2.058

8.  Structural characterization of pharmaceutical heparins prepared from different animal tissues.

Authors:  Li Fu; Guoyun Li; Bo Yang; Akihiro Onishi; Lingyun Li; Peilong Sun; Fuming Zhang; Robert J Linhardt
Journal:  J Pharm Sci       Date:  2013-03-21       Impact factor: 3.534

9.  Polymer - Nanoparticle Assemblies for Array Based Sensing.

Authors:  Brian Creran; Uwe H F Bunz; Vincent M Rotello
Journal:  Curr Org Chem       Date:  2015-06       Impact factor: 2.180

10.  Method to detect contaminants in heparin using radical depolymerization and liquid chromatography-mass spectrometry.

Authors:  Guoyun Li; Chao Cai; Lingyun Li; Li Fu; Yuqing Chang; Fuming Zhang; Toshihiko Toida; Changhu Xue; Robert J Linhardt
Journal:  Anal Chem       Date:  2013-12-23       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.